Angiotensin-I Converting Enzyme Inhibitors as Potential Anti-Angiogenic Agents for Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|4|7|555-567

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.4, Iss.7, 2004-11, pp. : 555-567

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structure Based Drug Design of Angiotensin-I Converting Enzyme Inhibitors

By  

Current Medicinal Chemistry, Vol. 19, Iss. 6, 2012-02 ,pp. : 845-855

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Vascular Endothelial Growth Factor Receptor (VEGFR) Kinase Inhibitors as Anti-Angiogenic Agents in Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 11, Iss. 6, 2004-03 ,pp. : 731-745

Bentham Science Publishers

Access to resources Recommend Favorite

Dipeptide Inhibitors of Thermolysin and Angiotensin I-Converting Enzyme

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 16, 2012-08 ,pp. : 1748-1762

Bentham Science Publishers

Access to resources Recommend Favorite

The Potential Role of Angiotensin Converting Enzyme and Vasopeptidase Inhibitors in the Treatment of Diabetic Neuropathy

By  

Current Drug Targets, Vol. 9, Iss. 1, 2008-01 ,pp. : 77-84

Bentham Science Publishers

Access to resources Recommend Favorite

Rapid and simple colorimetric assay for screening angiotensin I-converting enzyme inhibitors

By Wu Shanguang   Sun Jianhua   Tong Zhangfa   Lan Xiongdiao   Shu Bing   Liu Youyan   Liao Dankui  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 50, Iss. 10, 2012-10 ,pp. : 1303-1309

Informa Healthcare

Access to resources Recommend Favorite